Physician profile
Heidi E Helgeson
NPI 1740474931
$1,347.31
in general payments reported to CMS, 2019-2025
25 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $110 · 2021: $266 · 2022: $222 · 2023: $299 · 2024: $138 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.59 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $172.21 | 2019-2024 | Airsupra, Breztri, Farxiga |
| Mylan Specialty L.P. | $50.81 | 2019-2023 | Yupelri |
| Pfizer INC. | $49.88 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $46.57 | 2019-2021 | |
| Agile Therapeutics, INC. | $43.41 | 2021 | |
| Pacira Therapeutics, INC. | $33.83 | 2019 | |
| Novo Nordisk INC | $33.69 | 2019-2020 | |
| Gilead Sciences, INC. | $32.93 | 2021-2023 | |
| Medtronic, INC. | $32.76 | 2021-2023 | Minimed 780g |
| Allergan, INC. | $29.60 | 2020 | |
| Astellas Pharma US INC | $29.08 | 2023-2024 | Veozah, Myrbetriq |
| Vanda Pharmaceuticals INC. | $28.75 | 2025 | Fanapt |
| Sunovion Pharmaceuticals INC. | $27.89 | 2020 | |
| Xeris Pharmaceuticals, INC. | $26.95 | 2023-2025 | Gvoke Hypopen |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicomp INC | $22.72 | 2022 | |
| Harmony Biosciences LLC | $22.48 | 2023 | Wakix |
| Depuy Synthes Sales INC. | $19.62 | 2024 | Monovisc, Orthovisc |
| Eisai INC. | $18.20 | 2021 | |
| Medtronic Minimed, INC. | $17.65 | 2020 | |
| Optos, INC. | $16.88 | 2022 | |
| Lilly USA, LLC | $16.79 | 2023 | Mounjaro |
| Braeburn INC. | $16.02 | 2024 | Brixadi |
| Ultragenyx Pharmaceutical INC. | $15.10 | 2021 | |
| Bioventus LLC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Helgeson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.